Insider Trading May 4, 2026 07:07 PM

Tesla Director Kathleen Wilson-Thompson Executes $9.98 Million Stock Sale

The transaction, conducted under a pre-arranged trading plan, comes amid shifting regional market dynamics and varied analyst valuations.

By Marcus Reed TSLA
Tesla Director Kathleen Wilson-Thompson Executes $9.98 Million Stock Sale
TSLA

Kathleen Wilson-Thompson, a member of the board of directors for Tesla, Inc. (NASDAQ:TSLA), has completed a sale of common stock totaling approximately $9.98 million. The transaction took place on April 30, 2026, involving 27,389 shares. These sales were executed at various price points, ranging from $369.01 to $384.284 per share. This activity occurred following the exercise of 40,948 non-qualified stock options by Ms. Wilson-Thompson, which were valued at $613,810 and had been acquired at a price of $14.99 per share. These specific options had reached full vesting status as of June 18, 2022.The reported stock sales were not spontaneous but were carried out according to a Rule 10b5-1 trading plan that Ms. Wilson-Thompson had established on November 26, 2025. Following the completion of these transactions, Ms. Wilson-Thompson maintains a direct holding of 48,399 shares of Tesla common stock.

Key Points

  • Tesla director Kathleen Wilson-Thompson sold approximately $9.98 million in shares under a 10b5-1 plan.
  • The company faces diverse international pressures, including declining registrations in Portugal and order dips in China.
  • Analyst opinions vary significantly, with price targets ranging from $360 to $510.

Tesla, Inc. (NASDAQ:TSLA) director Kathleen Wilson-Thompson has executed a significant sale of company stock, totaling roughly $9.98 million. The transaction, which occurred on April 30, 2026, involved the sale of 27,389 shares at prices varying between $369.01 and $384.284 per share.


Transaction Mechanics and Holdings

The movement in Ms. Wilson-Thompson's holdings followed her exercise of 40,948 non-qualified stock options. These options, which had been fully vested since June 18, 2022, allowed for the acquisition of common stock at a price of $14.99 per share, representing a total value of $613,810. The subsequent sale of shares was conducted under a Rule 10b5-1 trading plan, a mechanism established by Ms. Wilson-Thompson on November 26, 2025, to manage her equity transactions. After finalizing these recent moves, she directly holds 48,399 shares of the company's common stock.

Market Performance and Analyst Perspectives

At the time of reporting, Tesla shares are trading at $392.51. While the stock has seen a 37% increase over the last year, it has also experienced a 13% decline during the current year-to-date period. Valuation metrics present a complex picture; for instance, the company is currently trading at a P/E ratio of 361, which according to InvestingPro analysis, suggests the stock appears overvalued at its present levels.

Wall Street analysts remain divided on the automaker's trajectory. Cantor Fitzgerald has maintained an Overweight rating with a price target of $510.00, following Tesla's strong first-quarter performance where revenue, gross margin, and earnings exceeded expectations. This positive outlook is supported by a first-quarter free cash flow of $1,444 million, which outperformed the consensus estimate of negative $1,780 million. In contrast, Barclays has assigned an Equalweight rating with a lower price target of $360.00. Additionally, Tesla has filed to register approximately 304 million shares for CEO Elon Musk as part of his existing 2018 compensation package.


Regional Market Trends and Competition

Tesla is facing varied headwinds in international markets. In Portugal, data from the automobile industry association ACAP shows that Tesla registrations dropped by 32.8% in April compared to the previous year, totaling only 203 units. This downturn occurs even as sales of fully-electric passenger cars in the broader Portuguese market rose by 34.6%.

In China, competitive pressures are mounting. Goldman Sachs reported a 1% decrease in Tesla's weekly orders during Week 17 of 2026. During this same period, domestic competitors such as Nio and HIMA recorded notable gains. HIMA's growth was driven by the introduction of new models like the Seres M6 EV and EREV models. Furthermore, Nio has introduced the ONVO L80 SUV, a large five-seat vehicle built on the NT 3.0 platform. The ONVO L80 is being positioned to compete in the family SUV segment with pre-sale pricing below that of Tesla's Model Y, with deliveries slated to begin on May 15.


Key Analysis Points

  • Insider Liquidity and Valuation: The execution of sales via a Rule 10b5-1 plan highlights how executives manage equity amidst high P/E ratios. This impacts the broader automotive and equities sectors by signaling internal valuation perceptions.
  • Global Market Volatility: Discrepancies between Tesla's registration declines in Portugal and the rising electric vehicle trend there, alongside order dips in China, highlight regional volatility within the global automotive sector.
  • Competitive Landscape shifts: The rise of domestic Chinese brands like Nio and HIMA suggests a tightening market share environment for established EV manufacturers.

Risks and Uncertainties

  • Valuation Discrepancy Risk: With a P/E ratio of 361, the stock faces uncertainty regarding its ability to sustain current levels if growth does not align with high valuation expectations, impacting equity markets.
  • Competitive Pressure in China: The introduction of lower-priced alternatives like the ONVO L80 and the success of HIMA models present a direct risk to Tesla's market share in the critical Chinese automotive sector.
  • Regional Registration Volatility: The decline in Portuguese registrations despite a growing EV market suggests specific challenges in maintaining localized dominance, affecting global automotive logistics and sales projections.

Risks

  • High valuation concerns due to a P/E ratio of 361.
  • Increased competition from Chinese manufacturers like Nio and HIMA.
  • Declining registration trends in specific European markets like Portugal.

More from Insider Trading

Marcus & Millichap Director Executes Substantial Common Stock Purchase May 4, 2026 Patterson-UTI CEO Executes Multi-Million Dollar Stock Sale Amidst Year-to-Date Surge May 4, 2026 Snowflake Director Michael Speiser Executes $7.18 Million in Stock Sales May 4, 2026 Edwards Lifesciences Executive Executes Stock Transactions Amid Recent Financial Growth May 4, 2026 Entrada Therapeutics President and COO Executes Stock Sale via Rule 10b5-1 Plan May 4, 2026